Start Forschung Abteilungen / AGs / Institute Abhängiges Verhalten und Suchtmedizin Publikationen

Publikationen: Abhängiges Verhalten und Suchtmedizin

Adkins AE, Hack LM, Bigdeli TB, Williamson VS, McMichael GO, Mamdani M, Edwards A, Aliev F, Chan RF, Bhandari P, Raabe RC, Alaimo JT, Blackwell GG, Moscati AA, Poland RS, Rood B, Patterson DG, Walsh D, Collaborative Study of the Genetics of Alcoholism Consortium , Whitfield JB, Zhu G, Montgomery GW, Henders AK, Martin NG, Heath AC, Madden PA, Frank J, Ridinger M, Wodarz N, Soyka M, Zill P, Ising M, Nöthen MM, Kiefer F, Rietschel M, German Study of the Genetics of Addiction Consortium , Gelernter J, Sherva R, Koesterer R, Almasy L, Zhao H, Kranzler HR, Farrer LA, Maher BS, Prescott CA, Dick DM, Bacanu SA, Mathies LD, Davies AG, Vladimirov VI, Grotewiel M, Bowers MS, Bettinger JC, Webb BT, Miles MF, Kendler KS, Riley BP. Genomewide Association Study of Alcohol Dependence Identifies Risk Loci Altering Ethanol-response Behaviors in Model Organisms. Alcohol Clin Exp Res. 2017 415(5):911-927. Epub 2017 Feb 22.
Aksay SS, Bumb JM, Remennik D, Thiel M, Kranaster L, Sartorius A, Janke C. Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia. Neuropsychiatr Dis Treat. 2017 13:1389-1394.
Aksay SS, Hambsch M, Janke C, Bumb JM, Kranaster L, Sartorius A. Alcohol Use Disorder as a Possible Predictor of Electroconvulsive Therapy Response. J ECT. 2017 33(2):117-121. Epub 2016 Nov 8.
Becker A, Gerchen MF, Kirsch M, Ubl B, Subramaniapillai S, Diener C, Kühner C, Kiefer F, Kirsch P. Frontostriatal connectivity during reward anticipation. Z Psychol. 2017 225(3):232-243.
Becker A, Kirsch M, Gerchen MF, Kiefer F, Kirsch P. Striatal activation and frontostriatal connectivity during non-drug reward anticipation in alcohol dependence. Addict Biol. 2017 22(3):833-843.
Bourque J, Spechler PA, Potvin S, Whelan R, Banaschewski T, Bokde AL, Bromberg U, Büchel C, Quinlan EB, Desrivieres S, Flor H, Frouin V, Gowland P, Heinz A, Ittermann B, Martinot JL, Paillere-Martinot ML, McEwen SC, Nees F, Orfanos DP, Paus T, Poustka L, Smolka MN, Vetter NC, Walter H, Schumann G, Garavan H, Conrod PJ, Mann K, Rietschel M, Spanagel R, Fauth-Bühler M, Millenet S, Grimmer Y, IMAGEN Consortium . Functional Neuroimaging Predictors of Self-Reported Psychotic Symptoms in Adolescents. Am J Psychiatry. 2017 174(6):566-575. Epub 2017 Mar 21.
Bumb JM, Kiefer F. Alkoholabhängigkeit im Wandel - was hat sich verändert?. Spectrum. Psychiatrie. 2017 19(6)
Bumb JM, Kiefer F. Nutzen von Stimulanzien zur kognitiven Leistungssteigerung fraglich. Kommentar zu "Stimulanzien verbessern Entscheidungsfindung - zumindest wenn Zeit keine Rolle spielt". InFo Neurol & Psychiatr. 2017 19(6):21.
Büchel C, Peters J, Banaschewski T, Bokde AL, Bromberg U, Conrod PJ, Flor H, Papadopoulos D, Garavan H, Gowland P, Heinz A, Walter H, Ittermann B, Mann K, Martinot JL, Paillere-Martinot ML, Nees F, Paus T, Pausova Z, Poustka L, Rietschel M, Robbins TW, Smolka MN, Gallinat J, Schumann G, Knutson B, Spanagel R, Fauth-Bühler M, Millenet S, Grimmer Y, IMAGEN consortium . Blunted ventral striatal responses to anticipated rewards foreshadow problematic drug use in novelty-seeking adolescents. Nat Commun. 2017 8:14140.
Czapla M, Baeuchl C, Simon JJ, Richter B, Kluge M, Friederich HC, Mann K, Herpertz SC, Loeber S. Do alcohol-dependent patients show different neural activation during response inhibition than healthy controls in an alcohol-related fMRI go/no-go-task?. Psychopharmacology (Berl). 2017 234(6):1001-1015.
Dieter J, Hoffmann S, Mier D, Reinhard I, Beutel M, Vollstädt-Klein S, Kiefer F, Mann K, Leménager T. The role of emotional inhibitory control in specific internet addiction - an fMRI study. Behav Brain Res. 2017 324:1-14. Epub 2017 Feb 4.
Erk S, Mohnke S, Ripke S, Lett TA, Veer IM, Wackerhagen C, Grimm O, Romanczuk-Seiferth N, Degenhardt F, Tost H, Mattheisen M, Mühleisen TW, Charlet K, Skarabis N, Kiefer F, Cichon S, Witt SH, Nöthen MM, Rietschel M, Heinz A, Meyer-Lindenberg A, Walter H. Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains. Transl Psychiatry. 2017 7(1):e997.
Fauth-Bühler M, Mann K. Neurobiological correlates of internet gaming disorder: Similarities to pathological gambling. Addict Behav. 2017 64:349-356. Epub 2015 Nov 24.
Fauth-Bühler M, Mann K, Potenza MN. Pathological gambling: a review of the neurobiological evidence relevant for its classification as an addictive disorder. Addict Biol. 2017 22(4):885-897. Epub 2016 Mar 3.
Frischknecht U. Werden Menschen mit Suchterkrankungen in der ambulanten Psychotherapie stigmatisiert?. Verhaltenstherap & psychosoz Prax. 2017 49:325-333.
Frischknecht U, Hermann D, Tunc-Skarka N, Wang GY, Sack MS, van Eijk J, Demirakca T, Falfán-Melgoza C, Krumm B, Dieter S, Spanagel R, Kiefer F, Mann KF, Sommer WH, Ende G, Weber-Fahr W. Negative Association Between MR-Spectroscopic Glutamate Markers and Gray Matter Volume After Alcohol Withdrawal in the Hippocampus: A Translational Study in Humans and Rats. Alcohol Clin Exp Res. 2017 41(2):323-333.
Groh A, Jahn K, Burkert A, Neyazi A, Schares L, Janke E, Rehme M, Schuster R, Hillemacher T, Bleich S, Frieling H, Heberlein A. Epigenetic Regulation of the Promotor Region of Vascular Endothelial Growth Factor-A and Nerve Growth Factor in Opioid-Maintained Patients. Eur Addict Res. 2017 23(5):249-259. Epub 2017 Dec 8.
Hasin DS, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Robinson RL, Anton R, Alcohol Clinical Trials Initiative (ACTIVE) Workgroup . Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population. Lancet Psychiatry. 2017 4(6):469-476. Epub 2017 Apr 26.
Havemann-Reinecke U, Hoch E, Preuss UW, Kiefer F, Batra A, Gerlinger G, Hauth I. [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics]. Nervenarzt. 2017 88(3):291-298. Epub 2016 Dec 15.
Heberlein A, Schuster R, Kleimann A, Groh A, Kordon A, Opfermann B, Lichtinghagen R, Gröschl M, Kornhuber J, Bleich S, Frieling H, Hillemacher T. Joint Effects of the Epigenetic Alteration of Neurotrophins and Cytokine Signaling: A Possible Exploratory Model of Affective Symptoms in Alcohol-Dependent Patients?. Alcohol Alcohol. 2017 52(3):277-281.
Heilig M, Barbier E, Johnstone AL, Tapocik J, Meinhardt MW, Pfarr S, Wahlestedt CR, Sommer WH. Reprogramming of mPFC transcriptome and function in alcohol dependence. Genes Brain Behav. 2017 16(1):86-100. Epub 2016 Sep 22.
Hermann D, Hirth N, Reimold M, Batra A, Smolka MN, Hoffmann S, Kiefer F, Noori HR, Sommer WH, Reischl G, la Fougère C, Mann K, Spanagel R, Hansson AC. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis. Neuropsychopharmacology. 2017 42(3):6063-614. Epub 2016 Aug 11.
Hinderhofer K, Mechler K, Hoffmann GF, Lampert A, Mountford WK, Ries M. Critical appraisal of genotype assessment in molybdenum cofactor deficiency. J Inherit Metab Dis. 2017 40(6):801-811. Epub 2017 Sep 12.
Juhás M, Sun H, Brown MR, MacKay MB, Mann KF, Sommer WH, Wilman AH, Dursun SM, Greenshaw AJ. Deep Grey Matter Iron Accumulation in Alcohol Use Disorder. Neuroimage. 2017 148:115-122. Epub 2017 Jan 5.
Koopmann A, Lippmann K, Schuster R, Reinhard I, Bach P, Weil G, Rietschel M, Witt SH, Wiedemann K, Kiefer F. Drinking water to reduce alcohol craving? A randomized controlled study on the impact of ghrelin in mediating the effects of forced water intake in alcohol addiction. Psychoneuroendocrinology. 2017 85:56-62. Epub 2017 Aug 5.
Kranaster L, Aksay SS, Bumb JM, Janke C, Sartorius A. The "Forgotten" Treatment of Alcohol Withdrawal Delirium With Electroconvulsive Therapy: Successful Use in a Very Prolonged and Severe Case. Clin Neuropharmacol. 2017 40(4):183-184. Epub 2017 Jun 16.
Lange B, Mueller JK, Leweke FM, Bumb JM. How gender affects the pharmacotherapeutic approach to treating psychosis - A systematic review. Expert Opin Pharmacother. 2017 18(4):351-362. Epub 2017 Jan 27.
Lett TA, Waller L, Tost H, Veer IM, Nazeri A, Erk S, Brandl EJ, Charlet K, Beck A, Vollstädt-Klein S, Jorde A, Kiefer F, Heinz A, Meyer-Lindenberg A, Chakravarty MM, Walter H. Cortical surface-based threshold-free cluster enhancement and cortexwise mediation. Hum Brain Mapp. 2017 38(6):2795-2807. Epub 2017 Mar 20.
Litten RZ, Falk DE, O'Malley SS, Witkiewitz K, Mann KF, Anton RF. Letter to Editor in Response to Johnson's Commentary (2017) on the Witkiewitz et al. (2017) Article. Alcohol Clin Exp Res. 2017 41(7):1381-1382. Epub 2017 May 4.
Mackey S, Chaarani B, Kan KJ, Spechler PA, Orr C, Banaschewski T, Barker G, Bokde AL, Bromberg U, Büchel C, Cattrell A, Conrod PJ, Desrivieres S, Flor H, Frouin V, Gallinat J, Gowland P, Heinz A, Ittermann B, Paillère Martinot ML, Artiges E, Nees F, Papadopoulos-Orfanos D, Poustka L, Smolka MN, Jurk S, Walter H, Whelan R, Schumann G, Althoff RR, Garavan H, Vollstädt-Klein S, Rietschel M, Schulze TG, Spanagel R, Diesch E, Gebicke-Haerter PJ, Kiefer F, Fauth-Bühler M, Millenet S, Grimmer Y, IMAGEN Consortium . Brain Regions Related to Impulsivity Mediate the Effects of Early Adversity on Antisocial Behavior. Biol Psychiatry. 2017 82(4):275-282. Epub 2016 Jan 18.
Mann K, Aubin HJ, Charlet K, Witkiewitz K. Can reduced drinking be a viable goal for alcohol dependent patients?. World Psychiatry. 2017 16(3):325-326.
Mann K, Aubin HJ, Witkiewitz K. Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?. Eur Addict Res. 2017 23(5):219-230. Epub 2017 Sep 22.
Mann K, Batra A, Fauth-Bühler M, Hoch E, and the Guideline Group . German Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders. Eur Addict Res. 2017 23(1):45-60.
Mann K, Kiefer F, Schellekens A, Dom G. Behavioural addictions: Classification and consequences. Eur Psychiatry. 2017 44:187-188. Epub 2017 Apr 28.
Mann K, Leménager T, Zois E, Hoffmann S, Nakovics H, Beutel M, Vogelgesang M, Wölfling K, Kiefer F, Fauth-Bühler M. Comorbidity, family history and personality traits in pathological gamblers compared with healthy controls. Eur Psychiatry. 2017 42:120-128. Epub 2016 Dec 23.
Mechler K, Hoffmann GF, Dittmann RW, Ries M. Defining the hidden evidence in autism research. Forty per cent of rigorously designed clinical trials remain unpublished - a cross-sectional analysis. INT J METH PSYCH RES. 2017 26(4):1546. Epub 2016 Nov 9..
Pätz T, Frischknecht U, Dinter C, Reinhard I, Mann K, Kiefer F, Weber T. Ergebnisse einer stationären Rauchentwöhnung bei Suchtpatienten im Rahmen einer 3-wöchigen, qualifizierten Entzugsbehandlung. Suchttherapie. 2017 18(03):140-149. Epub 2017 Feb 20.
Quaglio G, Schellekens A, Blankers M, Hoch E, Karapiperis T, Esposito G, Brand H, Nutt D, Kiefer F. A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European Union. Eur Addict Res. 2017 23(4):177-181. Epub 2017 Aug 12.
Roos CR, Mann K, Witkiewitz K. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone. Addict Biol. 2017 22(6):1528-1539. Epub 2016 Aug 2.
Saunders JB, Hao W, Long J, King DL, Mann K, Fauth-Bühler M, Rumpf HJ, Bowden-Jones H, Rahimi-Movaghar A, Chung T, Chan E, Bahar N, Achab S, Lee HK, Potenza M, Petry N, Spritzer D, Ambekar A, Derevensky J, Griffiths MD, Pontes HM, Kuss D, Higuchi S, Mihara S, Assangangkornchai S, Sharma M, Kashef AE, Ip P, Farrell M, Scafato E, Carragher N, Poznyak V. Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention. J Behav Addict. 2017 6(3):271-279. Epub 2017 Aug 17.
Schomerus G, Bauch A, Elger B, Evans-Lacko S, Frischknecht U, Klingemann H, Kraus L, Kostrzewa R, Rheinländer J, Rummel Ch, Schneider W, Speerforck S, Stolzenburg S, Sylvester E, Tremmel M, Vogt I, Williamson L, Heberlein A, Rumpf HJ. Das Stigma von Suchterkrankungen verstehen und überwinden : Memorandum. Sucht. 2017 63(5):253-259.
Schuster R, Gavas F, Schneider U, Glahn A, Hillemacher T, Frischknecht U, Reinhard I, Kleimann A, Bleich S, Heberlein A. Stigmatisierung Alkoholabhängiger : Einstellungen von Betroffenen während einer stationären Entzugsbehandlung, medizinischen Personals und Studierender. Sucht. 2017 63(5):261-268.
Schuster R, Kleimann A, Rehme MK, Taschner L, Glahn A, Groh A, Frieling H, Lichtinghagen R, Hillemacher T, Bleich S, Heberlein A. Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment. Eur Arch Psychiatry Clin Neurosci. 2017 267(1):33-40.
Schuster R, Koopmann A, Grosshans M, Reinhard I, Spanagel R, Kiefer F. Association of plasma calcium concentrations with alcohol craving: New data on potential pathways. Eur Neuropsychopharmacol. 2017 27(1):42-47. Epub 2016 Nov 24.
Spanagel R, Kiefer F. The Cannabinoid Receptor 1 as a Key Mediator of Adolescent Behavior. Neuropsychopharmacology. 2017 42(1):367.
Treutlein J, Frank J, Streit F, Reinbold CS, Juraeva D, Degenhardt F, Rietschel L, Witt SH, Forstner AJ, Ridinger M, Strohmaier J, Wodarz N, Dukal H, Foo JC, Hoffmann P, Herms S, Heilmann-Heimbach S, Soyka M, Maier W, Gaebel W, Dahmen N, Scherbaum N, Müller-Myhsok B, Lucae S, Ising M, Stickel F, Berg T, Roggenbuck U, Jöckel KH, Scholz H, Zimmermann US, Buch S, Sommer WH, Spanagel R, Brors B, Cichon S, Mann K, Kiefer F, Hampe J, Rosendahl J, Nöthen MM, Rietschel M. Genetic Contribution to Alcohol Dependence: Investigation of a Heterogeneous German Sample of Individuals with Alcohol Dependence, Chronic Alcoholic Pancreatitis, and Alcohol-Related Cirrhosis. Genes (Basel). 2017 8(7)
Völkening B, Schönig K, Kronenberg G, Bartsch D, Weber T. Deletion of psychiatric risk gene Cacna1c impairs hippocampal neurogenesis in cell-autonomous fashion. Glia. 2017 65(5):817-827.
Witkiewitz K, Hallgren KA, Kranzler HR, Mann K, Hasin DS, Falk DE, Litten RZ, O'Malley SS, Anton RF. Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels. Alcohol Clin Exp Res. 2017 41(1):179-186.
Witkiewitz K, Wilson AD, Pearson MR, Hallgren KA, Falk DE, Litten RZ, Kranzler HR, Mann K, Hasin DS, O'Malley SS, Anton RF. Temporal Stability of Heavy Drinking Days and Drinking Reductions among Heavy Drinkers in the COMBINE Study. Alcohol Clin Exp Res. 2017 41(5):1054-1062. Epub 2017 Mar 10.
Zois E, Kiefer F, Leménager T, Vollstädt-Klein S, Mann K, Fauth-Bühler M. Frontal cortex gray matter volume alterations in pathological gambling occur independently from substance use disorder. Addict Biol. 2017 22(3):864-872. Epub 2016 Jan 15.
Zois E, Vollstädt-Klein S, Hoffmann S, Reinhard I, Charlet K, Beck A, Jorde A, Kirsch M, Walter H, Heinz A, Kiefer F. Orbitofrontal structural markers of negative affect in alcohol dependence and their associations with heavy relapse-risk at 6 months post-treatment. Eur Psychiatry. 2017 46:16-22. Epub 2017 Aug 12.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de